unilad
Advert

Pfizer Says Its Coronavirus Vaccine Is 94% Effective In Over 65s

by : Emma Rosemurgey on : 18 Nov 2020 11:59
PA Images

Pfizer says its COVID-19 vaccine appears to protect 94% of adults above the age of 65.

It comes just a week after Pfizer and BioNTech released a report from its phase three trials, which revealed the vaccine had offered 90% protection against the deadly virus.

Advert

According to reports from the BBC, the two companies will now request authorisation for emergency use, so that the vaccine can be administered in the United States.

Pfizer makes vaccine possible for COVID 19Pfizer makes vaccine possible for COVID 19PA Images

The vaccine is currently in the third phase of trials, with two doses being administered to more than 41,000 people around the world. This was based on 94 people with confirmed coronavirus cases being given the vaccination, while the majority of people were given a dummy jab.

The data presented today comes from a group of 170 volunteers – eight of which were given the vaccine.

Advert

Pfizer and BioNTech’s experimental approach to developing the vaccination involves injecting a part of the virus’s genetic code into a person, to allow their body to train its immune system against it.

Covid-19 Vaccine Candidate Is 90% Effective, Manufacturer SaysCovid-19 Vaccine Candidate Is 90% Effective, Manufacturer SaysPA Images

As phase three trials continue, it’s likely that the success rate could change, as the sample size changes. However, with regulators confirming earlier this year that they would authorise vaccines with a 50% success rate or above, these preliminary phase three results seem very promising.

In a press conference last week, Boris Johnson announced the UK had already put in an order for 40 million doses of the Pfizer/BioNTech candidate.

Advert

If you have a story you want to tell, send it to UNILAD via [email protected]

Most Read StoriesMost Read

Animals

Man Lets Giant Huntsman Spider Live In His Home For A Year

Emma Rosemurgey

Emma Rosemurgey is an NCTJ trained Journalist who started her career by producing The Royal Rosemurgey newspaper in 2004, which kept her family up to date with the goings on of her sleepy north east village. She graduated from the University of Central Lancashire in Preston and started her career in regional newspapers before joining Tyla (formerly Pretty 52) in 2017, and progressing onto UNILAD in 2019.

Topics: Health, Coronavirus, Pfizer, vaccine

Credits

BBC
  1. BBC

    Covid vaccine: Pfizer says it's '94% effective in over 65s'